Behind the headlines - Autumn 2022

14 November 2022
Autumn 2022

Eye health issues that are making the news - Autumn 2022.

Caffeine metabolite may slow child myopia progression in children

Short-sightedness was observed to progress more slowly in children taking a compound derived from coffee, according to a new study.

Researchers found that taking 7-methylxanthine (7-MX) – a caffeine metabolite licensed as a myopia treatment in Denmark since 2009 – was associated with smaller increases in axial elongation and refractive error.

Sign in to continue

Forgotten password?
Register

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Mike Horler FCOptom presents current treatment strategies for late wet AMD, diabetic oedema and branch vein occlusion.

AMD

The College is asking for feedback from members on changes to its patient leaflets.

The latest issue of OPO is a tribute to Dame Ida Mann, and celebrates leading female vision scientists.